About Invesco India Pharma and Healthcare Fund
Invesco India Pharma and Healthcare Fund is a sectoral / thematic fund managed by Invesco Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.
The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.
Tax on your gains
Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.
Work out what you would owe with the capital gains tax calculator.
Every plan and option, with scheme codes
| Plan | Option | NAV | Scheme code |
|---|---|---|---|
| Direct | Growth | ₹10.05 | 154547 |
| Direct | IDCW | ₹10.05 | 154546 |
| Regular | Growth | ₹10.04 | 154545 |
| Regular | IDCW | ₹10.04 | 154544 |
Frequently asked questions
What is the NAV of Invesco India Pharma and Healthcare Fund today?
The NAV of Invesco India Pharma and Healthcare Fund (Direct plan, Growth) is ₹10.05 and the Regular plan NAV is ₹10.04, as of 18 Sept 2026.
What returns has Invesco India Pharma and Healthcare Fund given?
Over the last year the Direct plan returned –. Past returns do not guarantee future returns.
How much has Invesco India Pharma and Healthcare Fund fallen in the past?
Its deepest fall was 1.4% from 10 Sept 2026 to 16 Sept 2026.
Which category does Invesco India Pharma and Healthcare Fund belong to?
It is a Sectoral / Thematic Fund from Invesco Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.
What is the difference between the Direct and Regular plan?
Both invest in the same portfolio. The Direct plan is bought straight from the fund house or a direct platform and has a lower expense ratio because no distributor commission is paid, so its NAV grows slightly faster over time.
How are gains from Invesco India Pharma and Healthcare Fund taxed?
Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.
Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.